CLOSE X

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE1788.0052 (+3 %)
PREV CLOSE ( ) 1736.00
OPEN PRICE ( ) 1748.25
BID PRICE (QTY) 1783.85 (2)
OFFER PRICE (QTY) 1787.15 (16)
VOLUME 4332
TODAY'S LOW / HIGH ( )1738.30 1810.60
52 WK LOW / HIGH ( )1382.1 2130
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 20-03 1978
Management Info
Srinivas Sadu - Chairman - Managing Director
Registered Office

Address Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘x’ Roads,D. P. Pally, Dundigal, Dundigal-gandimaisamma Mandal,Medchal- Malkajgiri District,
Hyderabad,
Telangana-500043

Phone 040 30510999

Email gland@glandpharma.com / investor@glandpharma.com

Website www.glandpharma.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
04Mar Gland Pharma gets USFDA’s tentative no
Gland Pharma has secured tentative approval from the United States Food..
04Mar Gland Pharma informs about press relea
Pursuant to Regulation 30 read with Part A of Schedule III of the Securi..
18Feb Gland Pharma informs about analyst meet
Gland Pharma has informed that it enclosed details of schedule of the An..
18Feb Gland Pharma informs about change in m
Gland Pharma has informed that Jitendra Gangwal has been appointed as Vi..
06Feb Gland Pharma gets USFDA’s approval for
Gland Pharma has received approval from the United States Food and Drug..
Financials
Rs. in Millions
QTR Dec 25 ANNUAL 25
Net Profit3078.4710897.53
Gross Profit 4124.56 14655.85
Operating Profit 4818.3416576.93
Net Sales 11775.1341161.49
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 15308.65 (2.16%)
M.Cap ( in Cr)19640.83
RPG Life Sciences (BSE)
 2032.90 (7.01%)
M.Cap ( in Cr)3362.22
Pfizer (BSE)
 4936.20 (1.37%)
M.Cap ( in Cr)22582.00
Kwality Pharma (BSE)
 1746.00 (3.95%)
M.Cap ( in Cr)1793.94
Concord Biotech (BSE)
 1086.20 (4.60%)
M.Cap ( in Cr)11378.58
Shareholding Pattern
PROMOTERS 51.83%
MUTUAL FUNDS/UTI 31.42%
NON-INSTITUTION 7.61%
FI/BANKS/INSURANCE 1.36%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data February 2026 Broking Complaints Data February 2026 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.